Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Early research (Phase 1)Study completedNCT01741012
What this trial is testing

Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
Wayne State University 37
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Large-scale testing (Phase 3)Study completedNCT00090285
What this trial is testing

An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)

Who this might be right for
Condylomata Acuminata
Merck Sharp & Dohme LLC 4,065
Large-scale testing (Phase 3)UnknownNCT01512784
What this trial is testing

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

Who this might be right for
HPVHIV
University of Milan 100
Large-scale testing (Phase 3)Study completedNCT00092495
What this trial is testing

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 3,055
Large-scale testing (Phase 3)Study completedNCT00337428
What this trial is testing

Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 843
Not applicableStudy completedNCT03083249
What this trial is testing

Gardasil Knowledge

Who this might be right for
HPV
Sarah Hostetter, MD 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464
What this trial is testing

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Who this might be right for
Idiopathic CD4 T Cell Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 54
Large-scale testing (Phase 3)Study completedNCT02993757
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 528
Early research (Phase 1)Ended earlyNCT00798265
What this trial is testing

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

Who this might be right for
Human Immunodeficiency VirusHuman Papillomavirus- 6, 11, 16, 18Adolescent+1 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT02363660
What this trial is testing

Gardasil Immunogenicity With Needle-Free Injection

Who this might be right for
HIV
Thai Red Cross AIDS Research Centre 150
Testing effectiveness (Phase 2)Study completedNCT00411749
What this trial is testing

V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 107
Post-approval studies (Phase 4)Study completedNCT01914367
What this trial is testing

Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®)

Who this might be right for
Infection With Human Papillomavirus
University Hospital, Ghent 12
Large-scale testing (Phase 3)Study completedNCT01462357
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,079
Not applicableStudy completedNCT01553994
What this trial is testing

Effectiveness Study of Gardasil on Condyloma

Who this might be right for
CondylomaGenital Warts
Lisen Arnheim Dahlstrom 500,000
Large-scale testing (Phase 3)Study completedNCT03431246
What this trial is testing

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Who this might be right for
Human Papillomavirus Vaccines
Laval University 32
Large-scale testing (Phase 3)Study completedNCT03158220
What this trial is testing

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 1,212
Large-scale testing (Phase 3)Active Not RecruitingNCT03998254
What this trial is testing

Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 6,000
Not applicableUnknownNCT03659110
What this trial is testing

Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice

Who this might be right for
Cervical Cancer
Beijing Chaoyang District Centre for Disease Control and Prevention 1,000
Load More Results